The Company is developing Teverelix® as a best-in-class market product for advanced prostate cancer patients with high CV risk and a first in class product for Acute Urinary Retention Relapse preventi ...
The COVID-19 pandemic highlighted an urgent need for efficient, durable, and widely accessible vaccines. This prompted several important innovations in vaccine technology, and researchers continue to ...
The SBM100B is an optical MEMS digital output microphone delivering 80dB signal-to-noise ratio (SNR), 146dB SPL acoustic overload point (AOP), and a dynamic range of 132dB, far outperforming the ...
DUBAI, UAE, Feb. 5, 2026 /PRNewswire/ -- Dubai Science Park, the Middle East's leading science-focused hub, is celebrating two decades of enabling science and nurturing the region's research and ...
Relay Therapeutics gets US FDA Breakthrough Therapy Designation for zovegalisib to treat advanced breast cancer: Cambridge, Massachusetts Thursday, February 5, 2026, 16:00 Hrs [IS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results